Pharmaceutical Wastewater Treatment Chemicals

Products for complex organics, biological recovery, nitrogen removal, foam, evaporation and membrane systems.

Pharmaceutical wastewater can vary by product campaign and cleaning schedule and may contain concentrated organics, aromatic compounds, solvents, salts or inhibitory residues. Equalization and source segregation are essential before biological products are selected.

GZXZEP supplies selected microbial cultures, carbon sources, defoamers and RO chemicals for applications where wastewater characterization and controlled trials support their use.

Match Your Treatment Challenge to the Right Product

Biological Treatment for Complex Organics

XZ8811 is a broad COD-degrading culture. XZ8831 is intended for persistent aromatic compounds. Any trial should first assess inhibition and should not replace source control or pretreatment for concentrated solvents and active ingredients.

Link: Explore Microbial Treatment Products

Nitrogen and Process Recovery

XZ8821 and XZ8822 address the aerobic and anoxic nitrogen stages. NBC-70W or NBC-44WS may supply carbon for denitrification. XZ8809 may support biomass recovery after the inhibitory cause is corrected.

Link: Explore External Carbon Sources for Denitrification

Link: Explore Microbial Treatment Products

Foam Evaporation and RO Support

XZ8605 is for general wastewater foam, while XZ-0188 is intended for MVR service. RO products should be selected using feedwater analysis, membrane compatibility and foulant identification.

Link: Explore Wastewater Treatment Chemicals

Link: Explore RO Membrane Treatment Chemicals

Application Based Evaluation and Technical Support

1. Review the treatment challenge. Share the wastewater source, process layout, recent analysis, operating conditions and treatment target.
2. Select the relevant evaluation. Use a test suited to the product, such as jar testing, biological trials, foam testing, odor-contact trials or membrane compatibility review.
3. Run a controlled site trial. Record baseline conditions, dosing point, product consumption and the indicators relevant to the selected treatment.
4. Optimize the treatment program. Adjust the product and dose using operating data and check downstream effects before routine use.

GZXZEP provides product selection, laboratory evaluation and application support. Final performance depends on wastewater characteristics, process conditions, equipment and site operation.

Frequently Asked Questions

Can microbial products treat concentrated solvent wastewater directly?

Not automatically. Source segregation, solvent recovery or pretreatment may be required, and inhibition must be evaluated before a biological trial.

Which product is relevant to aromatic compounds?

XZ8831 is the listed aromatic-ring degradation microbial consortium.

Can the same defoamer be used in aeration and MVR?

Use XZ8605 for general wastewater foam and evaluate XZ-0188 for MVR conditions. Do not substitute without testing.

What information is needed for product selection?

Provide the wastewater source, flow, recent analysis, current treatment process, chemicals now in use and the required discharge or reuse target. A sample may be requested after the initial review.

Discuss Your Pharmaceutical Wastewater Treatment Needs

Share the production campaign, wastewater composition, inhibitory compounds, treatment process and required endpoint.

Button: Request a Quote